Association between FTO gene polymorphisms and breast cancer: the role of estrogen

References

• Assi N, Moskal A, Slimani N, et al. A treelet transform analysis to relate nutrient patterns to the risk of hormonal receptor-defined breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr. 2016 Feb;19(2):242–254.
   PubMed Web of Science ®Google Scholar
• Eftekhari MH, Moradi M. Assessment of energy and macronutrients intake in breast cancer patients. JBUMS. 2009;11(3):60–66.
   Google Scholar
• Mirmalek SA, Elham KF. Clinical application of breast cancer biology review of literature. Iran J Surg. 2009;17(1):54–62.
   Google Scholar
• Ronkainen J, Huusko TJ, Soininen R, et al. Fat mass-and obesity-associated gene FTO affects the dietary response in mouse white adipose tissue. Sci Rep. 2015;18(5): 92–33.
   Google Scholar
• Yang ZQ, Liu G, Bollig-Fischer A, et al. Transforming properties of 8p11–12 amplified genes in human breast cancer. Cancer Res. 2010;70(21):8487–8497.
   PubMed Web of Science ®Google Scholar
• Akbari ME, Gholamalizadeh M, Doaei S, et al. FTO gene affects obesity and breast cancer through similar mechanisms: a new insight into the molecular therapeutic targets. Nutr Cancer. 2018;70(1):30–36.
   PubMed Web of Science ®Google Scholar
• Lorincz AM, Sukumar S. Molecular links between obesity and breast cancer. Endocr Relat Cancer. 2006 1;13(2):279–292.
   PubMed Web of Science ®Google Scholar
• Li G, Chen Q, Wang L, et al. Association between FTO gene polymorphism and cancer risk: evidence from 16,277 cases and 31,153 controls. Tumor Biol. 2012;33(4):1237–1243.
   PubMedGoogle Scholar
• Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med. 2003;348(17):1625–1638.
   PubMed Web of Science ®Google Scholar
• Cleary MP, Grossmann ME. Obesity and breast cancer: the estrogen connection. Endocrinology. 2009 Apr 16;150(6):2537–2542.
   PubMed Web of Science ®Google Scholar
• Doaei S, Hajiesmaeil M, Aminifard A, et al. Effects of gene polymorphisms of metabolic enzymes on the association between red and processed meat consumption and the development of colon cancer; a literature review. J Nutr Sci. 2018;7:26–32.
   PubMed Web of Science ®Google Scholar
• Kalantari N, Mohammadi NK, Izadi P, et al. A haplotype of three SNPs in FTO had a strong association with body composition and BMI in Iranian male adolescents. PloS One. 2018 Apr 20;13(4):e0195589.
   PubMed Web of Science ®Google Scholar
• Gholamalizadeh M, Doaei S, Akbari ME, et al. Influence of fat mass-and obesity-associated genotype, body mass index, and dietary intake on effects of iroquois-related homeobox 3 gene on body weight. Chin Med J (Engl). 2018;131(17): 2113–2.
   PubMed Web of Science ®Google Scholar
• Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010 Sep 1;25(9):603–605.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):234–241.
   Web of Science ®Google Scholar
• Zeng X, Ban Z, Cao J, et al. Association of FTO mutations with risk and survival of breast cancer in a Chinese population. Dis Markers. 2015;5:1–6.
   Google Scholar
• da Cunha PA, de Carlos Back LK, Sereia AF, et al. Interaction between obesity-related genes, FTO and MC4R, associated to an increase of breast cancer risk. Mol Biol Rep. 2013;40:57–64.
   Web of Science ®Google Scholar
• Zhao Z, Wen W, Michailidou K, et al. Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry. Cancer Causes Control. 2016;27(5):79–93.
   Web of Science ®Google Scholar
• Kaklamani V, Yi N, Sadim M, et al. The role of the fat mass and obesity associated gene (FTO) in breast cancer risk. BMC Med Genet. 2011;12(1):52–59.
   PubMedGoogle Scholar
• Kusinska R, Górniak P, Pastorczak A, et al. Influence of genomic variation in FTO at 16q12. 2, MC4R at 18q22 and NRXN3 at 14q31 genes on breast cancer risk. Mol Biol Rep. 2012;39(3):15–19.
   Web of Science ®Google Scholar
• Brooks JD, Bernstein L, Teraoka SN, et al. Variation in genes related to obesity, weight, and weight change and risk of contralateral breast cancer in the WECARE Study population. Cancer Epidemiol Prev Biomarkers. 2012;21(12):61–67.
   PubMed Web of Science ®Google Scholar
• Mojaver M, Mokarian F, Kazemi M, et al. Specific TaqMan allelic discrimination assay for rs1477196 and rs9939609 single nucleotide polymorphisms of FTO gene demonstrated that there is no association between these SNPs and risk of breast cancer in Iranian women. Adv Biomed Res. 2015;4:136–143.
   PubMedGoogle Scholar
• Grant SF, Li M, Bradfield JP, et al. Association analysis of the FTO gene with obesity in children of Caucasian and African ancestry reveals a common tagging SNP. PloS One. 2008 Mar 12;3(3):17–22.
   Web of Science ®Google Scholar
• Akilzhanova A, Nurkina Z, Momynaliev K, et al. Genetic profile and determinants of homocysteine levels in Kazakhstan patients with breast cancer. Anticancer Res. 2013 1;33(9):49–59.
   Web of Science ®Google Scholar
• Garcia-Closas M, Couch FJ, Lindstrom S, et al. Genome-wide association studies identify four ER negative–specific breast cancer risk loci. Nat Genet. 2013;45(4):392.
   PubMed Web of Science ®Google Scholar
• Zhang B, Li Y, Li L, et al. Association study of susceptibility loci with specific breast cancer subtypes in Chinese women. Breast Cancer Res Treat. 2014;146(3):503–514.
   PubMed Web of Science ®Google Scholar
• Long J, Zhang B, Signorello LB, et al. Evaluating genome-wide association study-identified breast cancer risk variants in African-American women. PloS One. 2013;8(4):58–66.
   Web of Science ®Google Scholar
• Zheng W, Zhang B, Cai Q, et al. Common genetic determinants of breast-cancer risk in East Asian women: a collaborative study of 23 637 breast cancer cases and 25 579 controls. Hum Mol Genet. 2013;22(12):39–50.
   Web of Science ®Google Scholar
• Park SL, Cheng I, Pendergrass SA, et al. Association of the FTO obesity risk variant rs8050136 with percentage of energy intake from fat in multiple racial/ethnic populations: the PAGE study. Am J Epidemiol. 2013;178(5):80–90.
   Web of Science ®Google Scholar
• Fasching PA, Pharoah PD, Cox A, et al. The role of genetic breast cancer susceptibility variants as prognostic factors. Hum Mol Genet. 2012;21(17):26–39.
   PubMed Web of Science ®Google Scholar
• Cronin RM, Field JR, Bradford Y, et al. Phenome-wide association studies demonstrating pleiotropy of genetic variants within FTO with and without adjustment for body mass index. Front Genet. 2014;5:250–260.
   PubMed Web of Science ®Google Scholar
• Hou N, Zheng Y, Gamazon ER, et al. Genetic susceptibility to type 2 diabetes and breast cancer risk in women of European and African ancestry. Cancer Epidemiol Prev Biomarkers. 2012;21(3):552–556.
   PubMed Web of Science ®Google Scholar
• Kim B, Kim Y, Cooke PS, et al. The fused toes locus is essential for somatic-germ cell interactions that foster germ cell maturation in developing gonads in mice. Biol Reprod. 2011;84(5):1024–1032.
   PubMed Web of Science ®Google Scholar
• Jia G, Fu Y, Zhao X, et al. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol. 2011;7(12):885.
   PubMed Web of Science ®Google Scholar
• Freathy RM, Timpson NJ, Lawlor DA, et al. Common variation in the FTO gene alters diabetes-related metabolic traits to the extent expected given its effect on BMI. Diabetes. 2008;57(5):1419–1426.
   PubMed Web of Science ®Google Scholar
• Frayling TM, Timpson NJ, Weedon MN, et al. a common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007;316(5826):889–894.
   PubMed Web of Science ®Google Scholar
• Brennan P, McKay J, Moore L, et al. Obesity and cancer: mendelian randomization approach utilizing the FTO genotype. Int J Epidemiol. 2009;38(4):971–975.
   PubMed Web of Science ®Google Scholar
• Sarfstein R, Friedman Y, Attias-Geva Z, et al. Metformin downregulates the insulin/IGF-I signaling pathway and inhibits different uterine serous carcinoma (USC) cells proliferation and migration in p53-dependent or-independent manners. PloS One. 2013;8(4):e61537.
   PubMed Web of Science ®Google Scholar
• Huang X, Zhao J, Yang M, et al. Association between FTO gene polymorphism (rs9939609 T/A) and cancer risk: a meta‐analysis. Eur J Cancer Care (Engl). 2017;26(5):124–130.
   Web of Science ®Google Scholar
• Zhu Y, Shen J, Gao L, et al. Estrogen promotes fat mass and obesity-associated protein nuclear localization and enhances endometrial cancer cell proliferation via the mTOR signaling pathway. Oncol Rep. 2016 Apr 1;35(4):2391–2397.
   PubMed Web of Science ®Google Scholar
• Almén MS, Jacobsson JA, Moschonis G, Benedict C, Chrousos GP, Fredriksson R, Schiöth HB. Genome wide analysis reveals association of a FTO gene variant with epigenetic changes. Genomics. 2012;99(3):132–137.
   Google Scholar